Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi‐Zhou Jiang, Zhi‐Ming Shao, Ding Ma et al.|Nature Cancer|2024Cited by 85
A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trialYuxiang Ma, Hongyun Zhao, Yunpeng Yang et al.|Nature Medicine|2025Cited by 76
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancerJia-Han Ding, Gen‐Hong Di, Yi Xiao et al.|Molecular Therapy — Oncolytics|2022Cited by 40
Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory studyShen Zhao, Rongbo Lin, Nanfeng Fan et al.|Annals of Translational Medicine|2020Cited by 36
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancerShen Zhao, Wenfeng Fang|Nature Communications|2023Cited by 16